Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fish Oil-derived Omega-3 Fatty Acids on Gut Microbiota and Lipid Metabolome in Type 2 Diabetes Mellitus: a Randomized, Double-blind, Placebo-Controlled Clinical Trial

NCT06061510 is registered in ClinicalTrials.gov with Southeast University, China as lead sponsor.

NCT NCT06061510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06061510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fish Oil-derived Omega-3 Fatty Acids on Gut Microbiota and Lipid Metabolome in Type 2 Diabetes Mellitus: a Randomized, Double-blind, Placebo-Controlled Clinical Trial
Lead sponsor
Southeast University, China
Phase
Not applicable
Overall status
Completed
Start date
June 8, 2019
Completion date
January 31, 2020
Enrollment
110 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fatty acid metabolism disorder, lipid metabolism disorder, type 2 diabetes mellitus